Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Histopathology|October 22, 2013
Investigation of molecular alterations of AKT-3 in triple-negative breast cancerGillian O'Hurley, Etáin Daly, Anthony O'Grady, et al.
Breast Cancer Research and Treatment|November 3, 2012
Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumoursBrigid C Browne, Alex J Eustace, Susan Kennedy, et al.
Oncotarget|September 7, 2013
Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancerAlexandra Canonici, Merel Gijsen, Maeve Mullooly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancerDonal J Brennan, Elton Rexhepaj, Sallyann L O'Brien, et al.
International Journal of Cancer|January 6, 2007
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancerSallyann L O'Brien, Ailís Fagan, Edward J P Fox, et al.
EMBO Molecular Medicine|December 31, 2013
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasisMathilde Romagnoli, Nora D Mineva, Michael Polmear, et al.
Clinical Chemistry|October 5, 2012
Design of tumor biomarker-monitoring trials: a proposal by the European Group on Tumor MarkersGyörgy Sölétormos, Michael J Duffy, Daniel F Hayes, et al.
BMC Cancer|April 4, 2013
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancerPatrick C O Leary, Sarah A Penny, Roisin T Dolan, et al.
Clinical Chemistry|March 9, 2010
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancersCatharine M Sturgeon, Michael J Duffy, Barry R Hofmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2015
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor MarkersGyörgy Sölétormos, Michael J Duffy, Suher Othman Abu Hassan, et al.
Pageof 12